Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Hong Kong · Delayed Price · Currency is HKD 17.11
-0.53 (-3.00%)
Sep 10, 2026, 11:46 AM HKT
HKG:1877 Market Cap
HKG:1877 has a market cap or net worth of 33.53 billion as of September 9, 2026. Its market cap has decreased by -31.56% in one year.
Market Cap
33.53B
Enterprise Value
36.33B
Revenue
3.49B
Ranking
n/a
PE Ratio
n/a
Stock Price
17.11
ChartMarket Cap Chart
Since December 24, 2018, HKG:1877's market cap has increased from 18.06B to 33.53B, an increase of 85.66%. That is a compound annual growth rate of 8.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 33.52B | -3.29% |
| Dec 31, 2025 | 34.66B | 39.72% |
| Dec 31, 2024 | 24.81B | -37.28% |
| Dec 29, 2023 | 39.55B | -38.85% |
| Dec 30, 2022 | 64.67B | -7.04% |
| Dec 31, 2021 | 69.57B | -9.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Akeso | 88.43B |
| Genscript Biotech | 67.79B |
| RemeGen | 67.07B |
| Biocytogen Pharmaceuticals (Beijing) | 53.26B |
| 3SBio | 39.98B |
| Shanghai Henlius Biotech | 35.63B |
| InnoCare Pharma | 30.80B |
| Keymed Biosciences | 23.49B |